Pharma News

Mandibular Contour Surgery Training System Beneficial (Fri, 18 Jan 2019)
FRIDAY, Jan. 18, 2019 -- An intraoral mandibular contour surgery (MCS) training system is effective for improving clinical surgery time and accuracy, according to a study published online Jan. 17 in JAMA Facial Plastic Surgery. Jia Qiao, M.D., from...
>> Read more

Assessing Symptoms After 4 Weeks of Psychotherapy Helpful in Teens (Fri, 18 Jan 2019)
FRIDAY, Jan. 18, 2019 -- Therapists implementing interpersonal psychotherapy for depressed adolescents (IPT-A) should routinely monitor depression symptoms and consider augmenting treatment for insufficient responders as early as week 4 of...
>> Read more

Wait Times Have Improved in VA Health Care System (Fri, 18 Jan 2019)
FRIDAY, Jan. 18, 2019 -- From 2014 to 2017, there were improvements in wait times in the Department of Veterans Affairs (VA) health care system, resulting in reduced wait times versus the private sector (PS) in 2017, according to a study published...
>> Read more

Medication Treatment for Substance Abuse Up in Facilities (Fri, 18 Jan 2019)
FRIDAY, Jan. 18, 2019 -- From 2007 to 2016, there was an increase in the proportion of substance use treatment facilities offering medication treatment (MT), according to a study published in the January issue of Health Affairs. Using data from...
>> Read more

Mindfulness, Stress Linked to Menopausal Symptoms (Fri, 18 Jan 2019)
FRIDAY, Jan. 18, 2019 -- Higher mindfulness and lower stress are independently associated with lower menopausal symptom scores among midlife women, according to a study published online Jan. 17 in Climacteric. Richa Sood, M.D., from the Mayo Clinic...
>> Read more

Frailty Could Increase Susceptibility for Dementia (Fri, 18 Jan 2019)
FRIDAY, Jan. 18, 2019 -- Frailty and Alzheimer disease-related brain changes independently contribute to dementia status, according to a study published in the February issue of The Lancet Neurology. Lindsay M.K. Wallace, from the Nova Scotia Health...
>> Read more

Oral Hepatoselective Glucokinase Activator Promising in T2DM (Fri, 18 Jan 2019)
FRIDAY, Jan. 18, 2019 -- Use of the oral hepatoselective glucokinase activator (GKA) TTP399 for type 2 diabetes does not cause hypoglycemia and has no detrimental effect on plasma lipids or liver enzymes, according to a study published online Jan....
>> Read more